COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 2349: Articles 23481-23490  | Next

Methylene Blue has a potent antiviral activity against SARS-CoV-2 in the absence of UV-activation in vitro
Cagno, V., Medaglia, C., Cerny, A., Cerny, T., Tapparel, C., Cerny, E.
10.1101/2020.08.14.251090 — Posted: 2020-08-14
SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2
Heaton, B. E., Trimarco, J. D., Hamele, C. E., Harding, A. T., Tata, A., Zhu, X., Tata, P. R., Smith, C. M., Heaton, N. S.
10.1101/2020.08.14.251207 — Posted: 2020-08-14 Discussion: Offsite
Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction In Vitro
Olaleye, O. A., Kaur, M., Onyenaka, C. C., Adebusuyi, T. O.
10.1101/2020.08.14.250480 — Posted: 2020-08-14
Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering
Ong, E., Huang, X., Pearce, R., Zhang, Y., He, Y.
10.1101/2020.08.14.251496 — Posted: 2020-08-14
In Silico Design of siRNAs Targeting Existing and Future Respiratory Viruses with VirusSi
Zhang, D., Lu, J.
10.1101/2020.08.13.250076 — Posted: 2020-08-14
Differential methylation as a mediator of COVID-19 susceptibility
Steyaert, S., Trooskens, G., Delanghe, J. R., Van Criekinge, W.
10.1101/2020.08.14.251538 — Posted: 2020-08-14
Pandemic danger to the deep: the risk of marine mammals contracting SARS-CoV-2 from wastewater
Mathavarajah, S., Stoddart, A. K., Gagnon, G. A., Dellaire, G.
10.1101/2020.08.13.249904 — Posted: 2020-08-14 Discussion: Onsite
Methylation of RNA Cap in SARS-CoV-2 captured by serial crystallography
Wilamowski, M., Sherrell, D., Minasova, G., Kim, Y., Shuvaloca, L., Lavens, A., Chard, R., Maltseva, N., Jedrzejczak, R., Rosas-Lemus, M., Saint, N., Foster, I. T., Michalska, K., Satchell, K. J., Joachimiak, A.
10.1101/2020.08.14.251421 — Posted: 2020-08-14 Discussion: Onsite
SARS-CoV-2 manipulates the SR-B1-mediated HDL uptake pathway for its entry
Wei, C., Wan, L., Yan, Q., Wang, X., Zhang, J., Zhang, Y., Sun, J., Yang, X., Gong, J., Fan, C., Yang, X., Wang, Y., Wang, X., Li, J., Yang, H., Li, H., Zhang, Z., Wang, R., Du, P., Zong, Y., Yin, F., Zhang, W., Peng, Y., Lin, H., Zhang, R., Chen, W., Gao, Q., Cao, Y., Zhong, H.
10.1101/2020.08.13.248872 — Posted: 2020-08-14 Discussion: Onsite | Offsite
SARS-CoV-2 Infection And Longitudinal Fecal Screening In Malayan Tigers (Panthera tigris jacksoni), Amur Tigers (Panthera tigris altaica), And African Lions (Panthera leo krugeri) At The Bronx Zoo, New York, USA
Bartlett, S. L., Diel, D. G., Wang, L., Zec, S., Laverack, M., Martins, M., Caserta, L. C., Killian, M. L., Terio, K., Olmstead, C., Delaney, M. A., Stokol, T., Ivancic, M., Jenkins-Moore, M., Ingerman, K., Teegan, T., McCann, C., Thomas, P., McAloose, D., Sykes, J. M., Calle, P. P.
10.1101/2020.08.14.250928 — Posted: 2020-08-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).